Clinical Trial: IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus

Brief Summary: The purpose of this research study is to show that non-steroidal treatment with intravenous immunoglobulin (IVIg) can replace current systemic immunosuppressive therapy in cutaneous lupus erythematosis (CLE) patients.